86-MM0544.00-0250 - erdosteine | 84611-23-4
Spiacenti, non è stato trovato nessun prodotto con riferimento 86-MM0544.00-0250, ma La invitiamo a verificare i seguenti prodotti simili:
Erdosteine
CAS:Formula:C8H11NO4S2Purezza:>98.0%(GC)(T)Colore e forma:White to Almost white powder to crystalPeso molecolare:249.30Erdosteine
CAS:Erdosteine (RV 144), a mucolytic thiol, modulates mucus and aids expectoration, reduces cough, and protects lungs from smoke damage.Formula:C8H11NO4S2Purezza:99.65% - 99.94%Colore e forma:White Or Almost White Crystalline PowderPeso molecolare:249.31Ref: ST-EA-CP-E38000
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaErdosteine
CAS:Prodotto controllato<p>Applications Erdosteine is a mucolytic. Erdosteine was developed for the treatment of chronic obstructive bronchitis.<br>References Kuvandik, G., et al.: Toxicol. Pathol., 36, 714 (2008), Koyu, A., et al.: Mol. Cell. Biochem., 331, 43 (2009), Fourches, D., et al.: Chem. Res. Toxicol., 23, 171 (2010),<br></p>Formula:C8H11NO4S2Colore e forma:NeatPeso molecolare:249.31Erdosteine
CAS:<p>Erdosteine is a reactive molecule that is generated in the reaction solution and has been shown to have pro-apoptotic properties. It has been shown to protect against oxidative injury as it can react with reactive oxygen species, such as peroxynitrite, by converting them into less harmful molecules. Erdosteine also protects against neuronal death induced by 3-nitropropionic acid, which is a neurotoxin that inhibits mitochondrial respiratory chain complex I. Erdosteine may be used for the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The side-effect profiles of erdosteine are not well understood and more research needs to be done in order to determine if this drug could be used therapeutically.</p>Formula:C8H11NO4S2Purezza:Min. 95%Colore e forma:PowderPeso molecolare:249.31 g/mol









